Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 19, 2026
TickeronGET DAILY SIGNALS
iShares U.S. Tech Breakthrough Multisector ETF (TECB) Falls -10.4% Over the Past 30 Days

iShares U.S. Tech Breakthrough Multisector ETF (TECB) Falls -10.4% Over the Past 30 Days

Key Takeaways

  • The iShares U.S. Tech Breakthrough Multisector ETF (TECB) declined roughly 10.4% over the last 30 days, falling from about $77.64 to near $69.56.
  • The pullback extended a broader three-month trend, with the fund down approximately 7.6% over the last quarter despite remaining strongly positive on a year-to-date basis.
  • Information Technology accounts for roughly 58% of the portfolio, leaving the fund highly sensitive to swings in mega-cap technology and growth equities.
  • Top holdings such as Palo Alto Networks (PANW), Microsoft (MSFT), AMD (AMD), Palantir (PLTR), and NVIDIA (NVDA) have been central to the fund's recent volatility.
  • With a three-year equity beta near 1.36, TECB tends to amplify moves in the broader technology market.

TECB Overview and Portfolio Exposure

TECB is a passively managed ETF that seeks to track the NYSE FactSet U.S. Tech Breakthrough Index, a benchmark of U.S. companies positioned to benefit from five breakthrough technologies: robotics and artificial intelligence, cloud and data technology, cybersecurity, genomics and immunology, and financial technology (fintech). The fund holds approximately 178 securities and carries a net expense ratio of 0.30%.

The portfolio is concentrated in Information Technology (about 58%), with Health Care (roughly 14%), Financials (about 10%), and Communication Services (about 10%) providing secondary exposure. Its largest positions include Palo Alto Networks (PANW), Microsoft (MSFT), Advanced Micro Devices (AMD), Merck (MRK), Visa (V), Palantir (PLTR), Apple (AAPL), and NVIDIA (NVDA). This growth-oriented, technology-heavy structure explains why the fund can deliver strong gains during risk-on periods but also experience sharp drawdowns when sentiment toward high-multiple equities cools. I also checked this using Tickeron’s AI Screener to see how the holdings compare to peers.

TECB Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, TECB declined roughly 10.4%, from a closing price near $77.64 to approximately $69.56. The move was not a steady grind lower; instead, the fund traded up toward the $80 area in early October before reversing into a choppy, trend-driven decline that accelerated in early November with several large down days.

The last quarter tells a broader story. From a level near $75.26 three months ago, the fund has fallen about 7.6%, meaning a meaningful portion of the quarterly loss was concentrated in the most recent weeks. Notably, this decline comes after a strong run: the fund's net asset value (NAV, the per-share value of its underlying assets) total return remained up more than 25% year-to-date even after the pullback, underscoring how far the fund had risen before profit-taking set in.

What Drove TECB Price in the Last 30 Days

The recent decline was primarily a technology-led repricing. With roughly 58% of assets in Information Technology and a heavy weighting toward software, semiconductors, and artificial-intelligence-related names, TECB tracked the retreat in growth equities rather than any single company-specific event.

Several of the fund's largest holdings carry elevated valuations and are sensitive to shifts in interest-rate expectations and investor risk appetite. Positions such as Palantir (PLTR), CrowdStrike (CRWD), AMD (AMD), and NVIDIA (NVDA) are emblematic of the high-multiple, momentum-driven segments that led the downturn. Defensive and diversified names such as Visa (V) and Merck (MRK) provided only limited cushion against the broad tech selloff.

Because the fund's three-year equity beta is near 1.36, TECB tends to exaggerate the market's directional moves. When risk sentiment deteriorated, the fund fell faster than the broader equity market, reflecting its concentrated exposure to volatile, growth-oriented segments.

What Drove TECB Performance Over the Last Quarter

The three-month picture reflects a rotation away from richly valued technology and innovation themes. Earlier in the quarter, TECB benefited from continued enthusiasm around artificial intelligence, cloud infrastructure, and cybersecurity, helping push the fund toward its 52-week high above $80. As the quarter progressed, sentiment toward crowded, high-multiple growth trades cooled, and the fund surrendered those gains.

The concentration of the portfolio in mega-cap technology and software names means institutional positioning and sector rotation, rather than idiosyncratic company news, have been the dominant drivers. Health-care holdings tied to genomics and immunology, along with fintech names such as Visa (V) and Mastercard (MA), added diversification but did not offset the technology-heavy core. The result was a quarter characterized by an early advance followed by a meaningful correction.

Exploring Opportunities with the AI Screener

I often turn to Tickeron's AI Screener when analyzing funds like TECB. This AI-powered platform lets me scan thousands of securities with technical indicators, fundamentals, volatility metrics, and industry filters to identify trends and compare opportunities in technology and innovation themes more efficiently than manual methods.

TECB ETF Outlook: What Investors Should Watch Next

Going forward, the most important variables for TECB are the path of interest rates, inflation trends, and the durability of technology-sector earnings. Because the fund holds high-multiple growth names, changes in rate expectations can have an outsized impact on valuations and, by extension, the ETF's price.

Investors should also monitor earnings cycles among the fund's largest holdings, particularly in semiconductors, software, and cybersecurity, as well as developments in artificial-intelligence capital spending. Sector leadership, institutional flows into technology funds, and regulatory developments affecting large-cap technology companies all have the potential to influence the fund's trajectory. Continued strength in genomics, immunology, and fintech could provide diversification benefits, but the fund's concentrated technology exposure means its outlook remains closely tied to the broader market's appetite for growth and innovation themes.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TECB

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


TECB's Indicator enters downward trend

The Aroon Indicator for TECB entered a downward trend on November 18, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 152 similar instances where the Aroon Indicator formed such a pattern. In 133 of the 152 cases the stock moved lower. This puts the odds of a downward move at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TECB as a result. In 73 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.

TECB moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TECB crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TECB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TECB's RSI Oscillator exited the oversold zone, 25 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +3.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where TECB advanced for three days, in 311 of 357 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

TECB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Notable companies

The most notable companies in this group are Apple (NASDAQ:AAPL), NVIDIA Corp (NASDAQ:NVDA), Microsoft Corp (NASDAQ:MSFT), Alphabet (NASDAQ:GOOGL), Amazon.com (NASDAQ:AMZN), Meta Platforms (NASDAQ:META), VISA (NYSE:V), Advanced Micro Devices (NASDAQ:AMD), Mastercard (NYSE:MA), Merck & Co (NYSE:MRK).

Industry description

The investment seeks to track the investment results of the NYSE® FactSet® U.S. Tech Breakthrough IndexTM. The underlying index measures the performance of U.S. listed companies engaged in cutting edge research and development of products and services in the areas of robotics and artificial intelligence, cyber security, cloud and data tech, financial technology, and genomics and immunology. It generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index.

Market Cap

The average market capitalization across the iShares U.S. Tech Breakthrough Multisector ETF (TECB) ETF is 161.11B. The market cap for tickers in the group ranges from 477.2M to 5T. AAPL holds the highest valuation in this group at 5T. The lowest valued company is CTMX at 477.2M.

High and low price notable news

The average weekly price growth across all stocks in the iShares U.S. Tech Breakthrough Multisector ETF (TECB) ETF was 19%. For the same ETF, the average monthly price growth was 36%, and the average quarterly price growth was 325%. BILL experienced the highest price growth at 21%, while VIR experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the iShares U.S. Tech Breakthrough Multisector ETF (TECB) ETF was 2%. For the same stocks of the ETF, the average monthly volume growth was 23% and the average quarterly volume growth was -31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 63
P/E Growth Rating: 56
Price Growth Rating: 51
SMR Rating: 62
Profit Risk Rating: 79
Seasonality Score: 14 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
KLAR dropped -4.84% to $13.75 from Wednesday's close of $14.45, with the decline occurring during Thursday's regular session. JPMorgan downgraded the shares to Hold from Overweight and cut its price target to $17 from $20 in a note published before the open, extending a run of post-earnings target reductions.